Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.85 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.40 |
| ▸ | LSS | P48449 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL136689 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL29076360 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL7733446 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL7733130 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL133404 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25394046 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25391848 | 0.97 | CYP1A2 (0.81) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25392743 | 0.97 | CYP1A2 (0.81) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25391637 | 0.97 | CYP1A2 (0.81) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25393174 | 0.97 | CYP1A2 (0.81) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441901-B2 | Quantum dot ink composition, and quantum dot electroluminescent device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-14 | — | — | US | disclosed |
| WO-2025070677-A1 | INFRARED-ABSORBING FIBER AND FIBER PRODUCT | 住友金属鉱山株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2025070678-A1 | COMPLEX TUNGSTEN OXIDE PARTICLES, NEAR-INFRARED RAY ABSORBING PARTICLE DISPERSION LIQUID, AND NEAR-INFRARED RAY ABSORBING PARTICLE DISPERSION | 住友金属鉱山株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2025063217-A1 | INFRARED-ABSORBING PARTICLES, INFRARED-ABSORBING PARTICLE DISPERSION LIQUID, INFRARED-ABSORBING TRANSPARENT SUBSTRATE, INFRARED-ABSORBING PARTICLE DISPERSION, AND INFRARED-ABSORBING LAMINATED TRANSPARENT SUBSTRATE | 住友金属鉱山株式会社 | 2025-03-27 | — | — | WO | disclosed |
| WO-2024204328-A1 | INFRARED ABSORBING PARTICLES, INFRARED ABSORBING PARTICLE DISPERSION SOLUTION, INFRARED ABSORBING PARTICLE DISPERSION BODY, AND INFRARED ABSORBING LAMINATE | 住友金属鉱山株式会社 | 2024-10-03 | — | — | WO | disclosed |
| WO-2024195641-A1 | COMPLEX TUNGSTEN OXIDE PARTICLES, NEAR-INFRARED RAY ABSORBING PARTICLE DISPERSION LIQUID, AND NEAR-INFRARED RAY ABSORBING PARTICLE DISPERSION | 住友金属鉱山株式会社 | 2024-09-26 | — | — | WO | disclosed |
| WO-2023190758-A1 | COMPOSITE TUNGSTEN OXIDE PARTICLES, NEAR-INFRARED-ABSORBING PARTICLE DISPERSION LIQUID, AND NEAR-INFRARED-ABSORBING PARTICLE DISPERSION | 住友金属鉱山株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-20230287231-A1 | QUANTUM DOT INK COMPOSITION, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| CN-116606568-A | Quantum dot ink composition and quantum dot electroluminescent device | 三星电子株式会社 | 2023-08-18 | — | — | CN | disclosed |
| US-20230257607-A1 | QUANTUM DOT INK COMPOSITION, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| EP-0638075-B1 | THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS | OTSUKA PHARMA CO LTD (JP) | 2002-01-16 | — | — | EP | disclosed |
| US-6291129-B1 | LIGHT SENSITIVE ELEMENT WITH UNSATURATED POLYMERS | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-09-18 | — | — | US | disclosed |
| WO-1998043649-A2 | AGE PRODUCTION INHIBITORY COMPOSITION COMPRISING A MAILLARD REACTION INHIBITOR AND VITAMIN B¿6? | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-08 | — | — | WO | disclosed |
| US-5677322-A | THERAPY FOR AGING, DIABETES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-10-14 | — | — | US | disclosed |
| US-5422360-A | Hydrazonoimidazolidin-4-one derivatives; treatment of diabetes and aging disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-06-06 | — | — | US | disclosed |
| EP-0638075-A1 | THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-02-15 | — | — | EP | disclosed |
| WO-1994019335-A1 | THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-09-01 | — | — | WO | disclosed |
| EP-0531812-A1 | Maillard reaction inhibitor, process for producing it, composition containing it and the use thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-17 | — | — | EP | disclosed |
| EP-0450097-A1 | BENZOHETEROCYCLIC COMPOUNDS. | OTSUKA PHARMA CO LTD (JP) | 1991-10-09 | — | — | EP | disclosed |
| US-3992451-A | IN THE PRESENCE OF FREE RADICAL CATALYSTS, HYDROGEN CHLORIDE, AND CARBON MONOXIDE | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | disclosed |